Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Anal Cancer Metastatic × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 848 Neoplasms 563 Breast Neoplasms 531 Colorectal Neoplasms 403 Neoplasm Metastasis 349 Ovarian Neoplasms 294 Melanoma 292 Prostatic Neoplasms 280 Multiple Myeloma 274 Lung Neoplasms 266 Recurrence 262 Squamous Cell Carcinoma of Head and Neck 232 Leukemia, Myeloid, Acute 216 Pancreatic Neoplasms 209 Stomach Neoplasms 203 Endometrial Neoplasms 175 Triple Negative Breast Neoplasms 168 Carcinoma, Renal Cell 167 Lymphoma, Non-Hodgkin 160 Carcinoma, Hepatocellular 157 Small Cell Lung Carcinoma 145 Leukemia, Lymphocytic, Chronic, B-Cell 143 Advanced Solid Tumors 136 Lymphoma, Follicular 133 Lymphoma, Large B-Cell, Diffuse 131 Urinary Bladder Neoplasms 128 Glioblastoma 125 Uterine Cervical Neoplasms 124 Lymphoma 123 Head and Neck Neoplasms 123

Interventions

trifluridine tipiracil drug combination 1 reolysin 1 atezolizumab 1 Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07280377 2025-12-12

GOBLET

Oncolytics Biotech

Phase 1/2 Recruiting

Gastrointestinal

Anal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡